Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis
Rebecca A Chanoux, Ronald C Rubenstein, Ronald C Rubenstein
Frontiers in Pharmacology · 2012
doi:10.3389/fphar.2012.00137 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Cystic Fibrosis (CF) is the most common autosomal recessive lethal disorder among Caucasian populations. CF results from mutations and resulting dysfunction of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). CFTR is a cyclic AMP-dependent chloride channel that is localized to the apical membrane in epithelial cells where it plays a key role in salt and water homeostasis. An intricate network of molecular chaperone proteins regulates CFTR’s proper maturation and trafficking to the apical membrane. Understanding and manipulation of this network may lead to therapeutics for Cystic Fibrosis in cases where mutant CFTR has aberrant trafficking.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.